Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 6;9(11):e032707.
doi: 10.1136/bmjopen-2019-032707.

Characteristics and utilisation of the Mayo Clinic Biobank, a clinic-based prospective collection in the USA: cohort profile

Janet E Olson  1 , Euijung Ryu  2 , Matthew A Hathcock  2 , Ruchi Gupta  2 , Joshua T Bublitz  2 , Paul Y Takahashi  3 , Suzette J Bielinski  4 , Jennifer L St Sauver  4 , Karen Meagher  5 , Richard R Sharp  5 , Stephen N Thibodeau  6 , Mine Cicek  6 , James R Cerhan  4
Affiliations

Characteristics and utilisation of the Mayo Clinic Biobank, a clinic-based prospective collection in the USA: cohort profile

Janet E Olson et al. BMJ Open. .

Abstract

Purpose: The Mayo Clinic Biobank was established to provide a large group of patients from which comparison groups (ie, controls) could be selected for case-control studies, to create a prospective cohort with sufficient power for common outcomes and to support electronic health record (EHR) studies.

Participants: A total of 56 862 participants enrolled (21% response rate) into the Mayo Clinic Biobank from Rochester, Minnesota (77%, n=43 836), Jacksonville, Florida (18%, n=10 368) and La Crosse, Wisconsin (5%, n=2658). Participants were all Mayo Clinic patients, 18 years of age or older and US residents.

Findings to date: Overall, 43% of participants were 65 years of age or older and female participants were more frequent (59%) than males at all sites. Most participants resided in the Upper Midwest regions of the USA (Minnesota, Iowa, Illinois or Wisconsin), Florida or Georgia. Self-reported race among Biobank participants was 90% white. Here we provide examples of the types of studies that have successfully utilised the resource, including (1) investigations of the population itself, (2) provision of controls for case-control studies, (3) genotype-driven research, (4) EHR-based research and (5) prospective recruitment to other studies. Over 270 projects have been approved to date to access Biobank data and/or samples; over 200 000 sample aliquots have been approved for distribution.

Future plans: The data and samples in the Mayo Clinic Biobank can be used for various types of epidemiological and clinical studies, especially in the setting of case-control studies for which the Biobank samples serve as control samples. We are planning cohort studies with additional follow-up and acquisition of genetic information on a large scale.

Keywords: cohort; electronic health records; mayo clinic biobank.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Modified Consolidated Standards of Reporting Trials flow diagram. EHR, electronic health records.
Figure 2
Figure 2
Geographical distribution (state-level) of home residences among participants at the time of enrolment into the Mayo Clinic Biobank.
Figure 3
Figure 3
Geographical distribution (county-level) of home residences among Mayo Clinic Biobank participants from Upper Midwest regions (A) and Florida/Georgia (B).
Figure 4
Figure 4
Depth of electronic health records of Mayo Clinic Biobank participants since 1994.
See this image and copyright information in PMC

References

    1. Centers for Disease Control and Prevention Behavioral risk factor surveillance system. Available: https://www.cdc.gov/brfss/index.html [Accessed 9 Jan 2019].
    1. Ridgeway JL, Han LC, Olson JE, et al. . Potential bias in the bank: what distinguishes refusers, nonresponders and participants in a clinic-based biobank?. Public Health Genomics 2013;16:118–26. - PMC - PubMed
    1. Rocca WA, Yawn BP, St. Sauver JL, et al. . History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population. Mayo Clin Proc 2012;87:1202–13. 10.1016/j.mayocp.2012.08.012 - DOI - PMC - PubMed
    1. Rocca WA, Grossardt BR, Brue SM, et al. . Data resource profile: expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP). Int J Epidemiol 2018;47:368 10.1093/ije/dyx268 - DOI - PMC - PubMed
    1. Kim HT. Cumulative incidence in competing risks data and competing risks regression analysis. Clin Cancer Res 2007;13:559–65. 10.1158/1078-0432.CCR-06-1210 - DOI - PubMed

Publication types

LinkOut - more resources